Teladoc Health, Inc. Stockholders Equity

• Teladoc Health, Inc. showed a decrease of -7.1% in Stockholders Equity from 2024 to 2025.
• This data is from Teladoc Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2015: -$78.89 million | Q3 2015: $192.54 million | Q1 2016: $165.10 million | Q2 2016: $151.96 million | Q3 2016: $242.30 million | Q1 2017: $343.43 million | Q2 2017: $399.38 million | Q3 2017: $446.78 million | Q1 2018: $550.87 million | Q2 2018: $699.38 million | Q3 2018: $1.03 billion | Q1 2019: $1.00 billion | Q2 2019: $1.00 billion | Q3 2019: $993.74 million | Q1 2020: $1.00 billion | Q2 2020: $1.29 billion | Q3 2020: $2.23 billion | Q1 2021: $15.83 billion | Q2 2021: $16.00 billion | Q3 2021: $15.99 billion | Q1 2022: $9.14 billion | Q2 2022: $6.08 billion | Q3 2022: $6.05 billion | Q1 2023: $2.29 billion | Q2 2023: $2.30 billion | Q3 2023: $2.29 billion | Q1 2024: $2.29 billion | Q2 2024: $1.50 billion | Q3 2024: $1.51 billion | Q1 2025: $1.43 billion | Q2 2025: $1.42 billion | Q3 2025: $1.39 billion.
• Over the full 14 years of available data (2012 to 2025), Teladoc Health, Inc.'s Stockholders Equity has grown by 3,077.9%.
• Historical annual values: Fiscal year 2025: $1.39 billion | Fiscal year 2024: $1.49 billion | Fiscal year 2023: $2.33 billion | Fiscal year 2022: $2.31 billion | Fiscal year 2021: $16.05 billion | Fiscal year 2020: $15.88 billion | Fiscal year 2019: $1.01 billion | Fiscal year 2018: $1.01 billion | Fiscal year 2017: $558.90 million | Fiscal year 2016: $230.87 million | Fiscal year 2015: $178.56 million | Fiscal year 2014: -$67.54 million | Fiscal year 2013: -$55.45 million | Fiscal year 2012: -$46.53 million.
• Data sourced from SEC EDGAR public filings as of August 7, 2026.

Last verified: August 7, 2026